Cargando…

17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth

Preterm birth (PTB) is a major cause of infant mortality in the United States and around the globe. Makena(®)—once-a-week intramuscular injection of 17-α Hydroxyprogesterone caproate (17P)—is the only FDA approved treatment for the prevention of PTB. Invasive delivery of 17P requires hospitalization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patki, Manali, Giusto, Kiersten, Gorasiya, Samir, Reznik, Sandra E., Patel, Ketan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680947/ https://www.ncbi.nlm.nih.gov/pubmed/31337153 http://dx.doi.org/10.3390/pharmaceutics11070335

Ejemplares similares

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
por: Wadhwa, Jyoti, et al.
Publicado: (2015)

Vaginal Nanoformulations for the Management of Preterm Birth
por: Mir, Asad, et al.
Publicado: (2022)

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
por: Garcia, Stephanie M., et al.
Publicado: (2021)

Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth
por: Rouholamin, Safoura, et al.
Publicado: (2015)

Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020)

New hope for preventing preterm birth: The promise of vaginal nanoformulations
por: Reznik, Sandra E.
Publicado: (2022)

Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment
por: Patki, Manali, et al.
Publicado: (2021)

17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth – A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial
por: Kuon, Ruben-J., et al.
Publicado: (2021)

17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials
por: Almutairi, Abdulaali R., et al.
Publicado: (2021)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
por: Price, Joan T., et al.
Publicado: (2019)

Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution
por: Choi, Seung Ah, et al.
Publicado: (2022)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
por: Vidaeff, Alex C, et al.
Publicado: (2013)

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
por: Price, Joan T, et al.
Publicado: (2021)

17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
por: Baradwan, Saeed, et al.
Publicado: (2021)

Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
por: Dalal, Lena, et al.
Publicado: (2021)

Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing
por: Ali, Hany S. M., et al.
Publicado: (2022)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

The vaginal microbiome and preterm birth
por: Fettweis, Jennifer M., et al.
Publicado: (2019)

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
por: Travanty, Michael N, et al.
Publicado: (2018)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial
por: Combs, C Andrew, et al.
Publicado: (2011)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline
por: Nair, Anroop B., et al.
Publicado: (2022)

Investigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System
por: Al-Amodi, Yasir A., et al.
Publicado: (2020)

Race, the Vaginal Microbiome, and Spontaneous Preterm Birth
por: Sun, Shan, et al.
Publicado: (2022)

Microdiversity of the Vaginal Microbiome is Associated with Preterm Birth
por: Liao, Jingqiu, et al.
Publicado: (2023)

Microdiversity of the vaginal microbiome is associated with preterm birth
por: Liao, Jingqiu, et al.
Publicado: (2023)

Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability
por: Alhasani, Khalid F, et al.
Publicado: (2019)

3D Printing of Dapagliflozin Containing Self-Nanoemulsifying Tablets: Formulation Design and In Vitro Characterization
por: Algahtani, Mohammed S., et al.
Publicado: (2021)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
por: Parlak, Mesut, et al.
Publicado: (2015)

Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome
por: Homer, Michael V, et al.
Publicado: (2019)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
por: Corder-Ramos, Nicole L.B., et al.
Publicado: (2019)

The Prevalence of Vaginal Microorganisms in Pregnant Women with Preterm Labor and Preterm Birth
por: Choi, Seong Jin, et al.
Publicado: (2012)

Self-Nanoemulsifying System Loaded with Sildenafil Citrate and Incorporated within Oral Lyophilized Flash Tablets: Preparation, Optimization, and In Vivo Evaluation
por: Hosny, Khaled M., et al.
Publicado: (2020)

Preterm birth is associated with xenobiotics and predicted by the vaginal metabolome
por: Kindschuh, William F., et al.
Publicado: (2023)

17-hydroxyprogesterone quantification in dried blood spots by high performance liquid chromatography-tandem mass spectroscopy
por: Waller, Kate, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0o8g583h35aohrfrptrb19dg10